Literature DB >> 22795334

Amelioration of altered antioxidant enzymes activity and glomerulosclerosis by coenzyme Q10 in alloxan-induced diabetic rats.

Hassan Ahmadvand1, Majid Tavafi, Ali Khosrowbeygi.   

Abstract

Coenzyme Q10 is a natural antioxidant and scavenging free radicals. In the present study, we examined antioxidative activities of coenzyme Q10 and possible protective effect of coenzyme Q10 on in vivo and in vitro lipid peroxidation, antioxidant enzymes activity and glomerulosclerosis in alloxan-induced type 1 diabetic rats. Thirty Sprague-Dawley male rats were divided into three groups randomly: group 1 as control, group 2 as diabetic untreatment, and group 3 as treatments with coenzyme Q10 by 15 mg/kg i.p. daily, respectively. Diabetes was induced in the second and third groups by alloxan injection subcutaneously. After 8 weeks, animals were anaesthetized, liver and kidney were then removed immediately and used fresh or kept frozen until their lipid peroxidation analysis. Blood samples were also collected before killing to measure the lipid peroxidation and antioxidant enzymes activity. Kidney paraffin sections were prepared and stained by periodic acid-Schiff method. Glomerular volume and leukocyte infiltration were estimated by stereological rules and glomerular sclerosis was studied semi-quantitatively. Coenzyme Q10 significantly inhibited leukocyte infiltration, glomerulosclerosis and the levels of malondialdehyde (MDA) serum and kidney content in treated group compared with the diabetic untreated group. Coenzyme Q10 significantly inhibited LDL oxidation in vitro. Coenzyme Q10 significantly increased the serum levels of glutathione (GSH) and serum activity of catalase (CAT) and superoxide dismutase (SOD) in treated group compared with the diabetic untreated group. Coenzyme Q10 alleviates leukocyte infiltration and glomerulosclerosis and exerts beneficial effects on the lipid peroxidation and antioxidant enzymes activity in alloxan-induced type 1 diabetic rats. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22795334     DOI: 10.1016/j.jdiacomp.2012.06.004

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  22 in total

Review 1.  Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials.

Authors:  Noori Al-Waili; Hamza Al-Waili; Thia Al-Waili; Khelod Salom
Journal:  Redox Rep       Date:  2017-03-09       Impact factor: 4.412

2.  Protective effects of Withania somnifera root on inflammatory markers and insulin resistance in fructose-fed rats.

Authors:  Zahra Samadi Noshahr; Mohammad Reza Shahraki; Hassan Ahmadvand; Davood Nourabadi; Alireza Nakhaei
Journal:  Rep Biochem Mol Biol       Date:  2015-04

3.  Amelioration of altered serum, liver, and kidney antioxidant enzymes activities by sodium selenite in alloxan-induced diabetic rats.

Authors:  Hassan Ahmadvand; Maryam Ghasemi Dehnoo; Roohangiz Cheraghi; Bahram Rasoulian; Behrouzb Ezatpour; Mozhgan Azadpour; Kaveh Baharvand
Journal:  Rep Biochem Mol Biol       Date:  2014-10

4.  Neuroprotective effects of oleuropein against cognitive dysfunction induced by colchicine in hippocampal CA1 area in rats.

Authors:  Soheila Pourkhodadad; Masoud Alirezaei; Mehrnoush Moghaddasi; Hassan Ahmadvand; Manizheh Karami; Bahram Delfan; Zahra Khanipour
Journal:  J Physiol Sci       Date:  2016-02-18       Impact factor: 2.781

Review 5.  Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Authors:  Gerwyn Morris; George Anderson; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-06-13       Impact factor: 5.590

Review 6.  Diabetic nephropathy and antioxidants.

Authors:  Majid Tavafi
Journal:  J Nephropathol       Date:  2013-01-01

Review 7.  Activation of Nrf2 signaling by natural products-can it alleviate diabetes?

Authors:  Manuel Matzinger; Katrin Fischhuber; Elke H Heiss
Journal:  Biotechnol Adv       Date:  2017-12-28       Impact factor: 14.227

8.  Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats.

Authors:  Rajesh A Maheshwari; R Balaraman; Ashim K Sen; A K Seth
Journal:  Indian J Pharmacol       Date:  2014 Nov-Dec       Impact factor: 1.200

9.  Antiatherogenic, hepatoprotective, and hypolipidemic effects of coenzyme Q10 in alloxan-induced type 1 diabetic rats.

Authors:  Hassan Ahmadvand; Maryam Ghasemi-Dehnoo
Journal:  ARYA Atheroscler       Date:  2014-07

10.  Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, Tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats.

Authors:  Mohamed M Amin; Gihan F Asaad; Rania M Abdel Salam; Hanan S El-Abhar; Mahmoud S Arbid
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.